Linoleic Acid

1. INCI & CAS

INCI: Linoleic Acid · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Linoleic Acid is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Follow the supplier TDS for the finished formula's use range.

Refer to the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• A CosIng listing for Linoleic Acid provides ingredient information, not approval of a supplied grade or finished product.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Linoleic Acid is used, to be assessed rather than for an ingredient name alone.
• For Linoleic Acid, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; no drug approval or OTC status is conferred by this entry and the finished formula still needs patch and stability testing.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; where oxidation is a concern, evaluate airless or pump packaging; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• Names Linoleic Acid as a cosmetic ingredient on this SKU

• This cosmetic guide does not substantiate claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient record for Linoleic Acid does not support whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

This entry describes glycerin as a polyol humectant for gels, emulsions, and washes, with a guide level rather than a batch result.

3. Typical use levels (formulation guide)

• For gels and serums, the reference gives 3–8% for the formula.
• The stated reference for creams is 2–5% as a formulation guide.
• The level shown for rinse-off is 2–4% in this reference.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• If Glycerin appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Glycerin in the final product context.
• Use the supplier TDS to confirm grade-specific details for Glycerin and review the destination market's requirements.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; the note establishes neither drug approval nor OTC-monograph status and the completed formula still requires stability and patch testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; evaluate packaging against the formula's susceptibility to oxidation; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Glycerin highlights humectant function.

• The formulation note does not substantiate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The information about Glycerin offers no support for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• The level shown for gel-creams is 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% in this reference.
• The formulation record indicates 5–15% for balms as a formulation guide.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Regulatory sources & global compliance

• Database information on Squalane does not replace review of the supplied grade and finished product under market rules.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Squalane rather than for an ingredient name alone.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; no drug approval or OTC-monograph status follows from this guide while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; take oxidation sensitivity into account when selecting the final pack; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The available ingredient details does not demonstrate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The ingredient record for Squalane should not be cited in support of a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.